Abstract
To study the effect of mucosal inflammation on tissue concentrations of somatostatin, the distribution and concentration of somatostatin in specimens of normal and abnormal (ulcerative colitis and Crohn's disease) ileum and colon were determined by a specific radioimmunoasay. Each tissue specimen obtained at surgery was separated by microdissection into the mucosa-submucosa and the muscularis externa. Immunoreactive somatostatin was acid-extracted from each layer before measurement. Gel chromatography was used to characterize immunoreactive somatostatin measured by radioimmunoassay; somatostatin-28 was the major immunoreactive species measured in human intestine. In normal colon, concentrations of somatostatin were not related to patient age. Concentrations of immunoreactive somatostatin in the mucosa-submucosa of the descending colon were significantly decreased in ulcerative colitis and in Crohn's colitis, compared with normal colon. There was no apparent relationship between concentrations of somatostatin and the duration of inflammatory bowel disease. However, somatostatin concentrations appeared to be lower in patients with severe colitis than in patients with minimal colitis. The decrease in mucosal-submucosal concentrations of somatostatin is in agreement with previous morphologic studies, which have suggested diminished populations of endocrine cells in ulcerative colitis. The possible role of somatostatin in the colon suggests that further studies of the alteration of this gut peptide may be useful in understanding a component of the pathophysiology of idiopathic inflammatory bowel disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Masson MP. La glande endocrinaire de l'intestine chez l'homme. C R Acad Sci 1914;158:59–61.
Lehy T, Peranzi G, Cristina ML. Correlative immunocytochemical and electron microscopic studies: identification of (entero)-glucagon-somatostatin-and pancreatic polypeptide-like-containing cells in the human colon. Histochemistry 1981;71:67–80.
Grube D. Die endokrinen zellen des verdauungsapprarats. Klin Wochenschr 1982;60:213–7.
Costa M, Patel Y, Furness JB, Arimura A. Evidence that some intrinsic neurons of the intestine contain somatostatin. Neurosci Lett 1977;6:215–22.
Verity MA, Mellinkoff SM, Frankland M, Greipel M. Serotonin content and argentaffin and paneth cell changes in ulcerative colitis. Gastroenterology 1962;43:24–31.
Ahonen A, Kyösola K, Penttilä O. Enterochromaffin cells and macrophages in ulcerative colitis and irritable colon. Ann Clin Res 1976;8:1–7.
Kyösola K, Pentillä O, Salaspuro M. Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 1977;12:363–7.
Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 1980;79:853–60.
Angel F, Schmalz PF, Morgan KG, Go VL, Szurszewski JH. Innervation of the muscularis mucosa in the canine stomach and colon. Scand J Gastroenterol (suppl) 1982;71:71–5.
Robinson G, Dawson I. A formalin fixative for immunochemical and ultrastructural studies on gastrointestinal endocrine cells. J Clin Pathol 1979;32:40–5.
Gerich J, Greene K, Hara M, Rizza R, Patton G. Radioimmunoassay of somatostatin and its application in the study of pancreatic somatostatin secretionin vitro. J Lab Clin Med 1979;93:1009–17.
Greenwood FC, Hunter WM, Glover JS. The preparation of131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963;89:114–23.
Koch TR, Carney JA, Go VL. Distribution and quantitation of gut neuropeptides in normal intestine and the inflammatory bowel diseases. Dig Dis Sci 1987;32:369–76.
Ponder BA, Schmidt GH, Wilkinson MM, Wood MJ, Monk M, Reid A. Derivation of mouse intestinal crypts from single progenitor cells. Nature 1985;313:689–91.
Lumb G, Protheroe RH. Biopsy of the rectum in ulcerative colitis. Lancet 1955;2:1208–15.
Baldissera FG, Holst JJ, Jensen SL, Krarup T. Distribution and molecular forms of peptides containing somatostatin immunodeterminants in extracts from the entire gastrointestinal tract of man and pig. Biochim Biophys Acta 1985;838:132–43.
Agerskov K, Bousfield R, Mortensen PE, Olsen J, Christiansen J. Effect of somatostatin on133Xe clearance from colonic mucosa before and after local nervous blockade in unanaesthetized man. Scand J Gastroenterol 1986;21:951–4.
Dharmsathaphorn K, Sherwin RS, Dobbins JW. Somatostatin inhibits fluid secretion in the rat jejunum. Gastroenterology 1980;78:1554–8.
Dharmsathaphorn K, Binder HJ, Dobbins JW, Leo L. Somatostatin stimulates sodium and chloride absorption in the rabbit ileum. Gastroenterology 1980;78:1559–65.
Lehy T, Dubrasquet M, Bonfils S. Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion 1979;99:99–109.
Stange EF, Schneider A, Schusdziarra V, Ditschuneit H. Inhibitory effects of somatostatin on growth and differentiation in cultured intestinal mucosa. Horm Metab Res 1984;16:74–8.
Holmes SJ, Jaspan JB, Moossa AR. The effect of somatostatin on postresectional ileal hyperplasia. Endocrinology 1982;111:1397–9.
Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 1986;136:152–6.
Allan A, Bristol JB, Williamson RC. Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse. Gut 1985;26:999–1003.
Kanemitsu T, Koike A, Yamamoto S. Study of the cell proliferation kinetics in ulcerative colitis, adenomatous polyps, and cancer. Cancer 1985;56:1094–8.
Cooper JC, Williams NS, King RF, Barker MC. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg 1986;73:128–31.
Reasbeck PG. Somatostatin treatment of gastrointestinal fistulas: evidence for a rebound effect on withdrawal. Aust NZ J Surg 1984;54:465–7.
Geerdsen JP, Pedersen VM, Kjaergard HK. Small bowel fistulas treated with somatostatin: preliminary results. Surgery 1986;100:811–4.
Maton PN, O'Dorisio TM, Howe BA, et al. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med 1985;312:17–21.
Edwards C, Cann PA, Read NW, Holdsworth CD. Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea. Gut 1986;27:581–6.
Bauer W, Briner U, Doepfner W, et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982;31:1133–40.
Author information
Authors and Affiliations
Additional information
Dr. Koch is a recipient of a Career Development Award from the National Foundation for Ileitis and Colitis.
About this article
Cite this article
Koch, T.R., Carney, J.A., Morris, V.A. et al. Somatostatin in the idiopathic inflammatory bowel diseases. Dis Colon Rectum 31, 198–203 (1988). https://doi.org/10.1007/BF02552546
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02552546